[PDF] Top 20 Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
Has 10000 "Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus" found on our website. Below are the top 20 most common "Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus".
Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
... of epitopes mapped for other DENV ED3 complex- and subcomplex-specific neutralizing ...DENV complex- specific MAb 4E11 has an epitope on the DENV-1 ED3 pro- tein that includes ... See full document
10
Variable Surface Epitopes in the Crystal Structure of Dengue Virus Type 3 Envelope Glycoprotein
... group-specific epitopes poses the follow- ing ...recognize epitopes con- served among serotypes (e.g., those in domain II) also cross- neutralizing at a reasonable titer, or are ... See full document
9
Antibody Binding Modulates Conformational Exchange in Domain III of Dengue Virus E Protein
... Domain III of dengue virus E protein (DIII) participates in the recognition of cell receptors and in structural rearrangements required for membrane fusion and ultimately viral ... See full document
10
The Chimeric Protein Domain III-Capsid of Dengue Virus Serotype 2 (DEN-2) Successfully Boosts Neutralizing Antibodies Generated in Monkeys upon Infection with DEN-2
... recombinant protein, since the determination was not performed at day 0 of the booster ...chimeric protein, demonstrat- ing that epitopes of the viral regions present in the protein are able ... See full document
5
The Potent and Broadly Neutralizing Human Dengue Virus Specific Monoclonal Antibody 1C19 Reveals a Unique Cross Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
... prM protein and is comprised largely of serotype cross-reactive and weakly neutral- izing antibodies ...surface-exposed epitopes, are se- rotype specific or potently inhibitory (neutralizing ... See full document
12
Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection
... Zika virus (ZIKV) is an emerging flavivirus that can cause birth defects and neurologic ...and dengue virus (DENV) widely cocirculate, distin- guishing ZIKV infection from DENV infection is ... See full document
13
Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques
... nonreplicating dengue virus type 2 (DENV-2) vaccines: (i) a DNA vaccine containing the prM-E gene region (D), (ii) a recombinant subunit protein vaccine containing the B domain ... See full document
9
Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies
... 18–20). Protein binding-based assays performed to distinguish DENV and ZIKV infections, while critical for accurately diagnosing infection history (12, 20), may oversimplify the com- plex neutralizing ... See full document
6
The Helical Domains of the Stem Region of Dengue Virus Envelope Protein Are Involved in both Virus Assembly and Entry
... E protein is a determinant of tropism and virulence, as well as the major target of neutralizing and enhancing anti- bodies to DENV (2, 9, 13, 26, ...E protein revealed three domains (domains ... See full document
13
Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
... with dengue and West Nile virus are not mainly directed to well-studied neutralizing anti- body epitopes on EDIII (20, 27, ...recombinant protein antigens and the native protein ... See full document
5
A New Quaternary Structure Epitope on Dengue Virus Serotype 2 Is the Target of Durable Type Specific Neutralizing Antibodies
... ABSTRACT Dengue virus serotype 2 (DENV2) is widespread and responsible for severe ...from dengue cases and structure-guided design of a chimeric DENV, here we de- scribe the major site on the ... See full document
8
A Mouse Monoclonal Antibody against Dengue Virus Type 1 Mochizuki Strain Targeting Envelope Protein Domain II and Displaying Strongly Neutralizing but Not Enhancing Activity
... between neutralizing and en- hancing activities in serum is based on serum antibody species composition, the total antibody response induced by the E antigen molecule is affected by the ability of each epitope to ... See full document
10
Comparison of Plaque- and Enzyme-Linked Immunospot-Based Assays To Measure the Neutralizing Activities of Monoclonal Antibodies Specific to Domain III of Dengue Virus Envelope Protein
... EDIII protein of DENV-1, DENV-2, DENV-3, and DENV-4 (1), separately or mixed together, were used to immunize BALB/c mice as described previously ...EDIII protein from each dengue serotype as ... See full document
6
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
... For each individual MAb, the DENV-2 DIII mutant library was screened according to a previously described protocol (53). To identify yeasts that had selectively lost binding to a given MAb, the library was ... See full document
11
A novel platform for virus like particle display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodies
... reacting protein was detected as a major band of 37 kDa in apparent molecular weight (Figure 2A, left panel), whereas it was visible as a blurred band at 72-75 kDa in VLPs (Figure 2A, right ...RIgE protein ... See full document
18
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
... induced protein band was confirmed using antibodies specific to each of the two fusion partners as well as to the affinity tag by immunoblotting analyses (Figure ... See full document
6
Characterization and epitope mapping of Dengue virus type 1 specific monoclonal antibodies
... encephalitis virus (JEV) in different cross-reactivity ...and neutralizing activity against DV1 and showed no cross-reactivity to DV2, DV3, DV4 or JEV-infected cells as characterized by ELISA, dot blot, ... See full document
11
Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice
... ABSTRACT Dengue virus is the most globally prevalent mosquito-transmitted vi- ...of neutralizing antibodies, promote uptake of antibody-opsonized virus in Fc- ␥ receptor-positive ...broadly ... See full document
19
Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
... The initial description of EDE antibodies reported that they were immunodominant in nearly half of the study’s subjects (in- cluding one individual with a primary DENV infection), but there are several important caveats: ... See full document
8
The Length of and Nonhydrophobic Residues in the Transmembrane Domain of Dengue Virus Envelope Protein Are Critical for Its Retention and Assembly in the Endoplasmic Reticulum
... E protein, in which alanines inserted into the C terminus of T1 (corresponding to DENV E positions 457, 461, and 465) or T2 (DENV E positions 479, 483, and 487) helix did not affect the PrM-E interaction (53) and ... See full document
16
Related subjects